Programme - BPA 2020

BioProcessing Asia 2020 follows in the footsteps of the three previous highly successful BPA Conferences and moves to Singapore and the largest biotechnology cluster in the Asia/Asia-Pacific region. The conference addresses the most important issues facing the development of a dynamic, vibrant bioprocessing industry in Asia.

Six half-day Oral Sessions and an interactive Poster Session will provide conference participants with the latest innovations in bioprocessing and direct access to key international opinion leaders in the field.

The rapidly changing demographics in Asia generate an increasing demand for all types of affordable biopharmaceutical products from prevention to treatment. To a large extent, the ability to satisfy patient needs will rely on the ability of the Asian biopharmaceutical industry to research, develop and manufacture safe and efficacious products. For this, a dynamic and innovative R&D culture is required in concert with the development of high yielding, reliable, reproducible and sustainable processes.

BioProcessing Asia 2020 opens on Monday 26 October 2020 with a Keynote Address from a well-known opinion leader in the biopharmaceutical space.

The six Scientific Sessions of 5 talks each on Tuesday – Thursday cover all the different biological product modalities with a special look at gene and cell therapies. Sessions have a science and technology focus on process development and a pragmatic and reality-based look at new advances that contribute to improved efficiency and product quality. A final, forward-looking session will address the state of digitalization in the industry. A Poster Session will enable attendees to discuss the latest issues with presenters.

Please click on the session title to view more information about each session.

Monday 26 October 2020

Registration, Reception

Keynote Address - To be announced

Tuesday 27 October 2020


Session 1: Diseases, treatments and the future of biopharmaceuticals
Session chairs:

Arindam Bose, Former Vice-President, Biotherapeutics External Affairs & Biosimilars Strategy, Pfizer, Independent Biotechnology & Bioprocessing Consultant, AbiologicsB, LLC, Stonington, USA

Say Kong Ng, Senior Scientist, Bioprocessing Technology Institute, A*STAR, Agency for Science, Technology and Singapore-MIT Alliance, National University of Singapore, Singapore.


Session 2: The use of smart process development to improve process efficiency and product quality
Session chairs:

Stefan Hepbildikler, Director, Technology Pharma Bioprocess Development, Roche Pharmaceuticals, Munich, Germany

Min Zhu, Director, Protein Science, Boehringer Ingelheim, Fremont, USA

Wednesday 28 October 2020


Session 3: A reality check on flexible, integrated and continuous biomanufacturing
Session chairs:

Wei (Heidi) Gong, Senior Director of Bridge Manufacturing, Shanghai Henlius Biopharmaceutical Co., Ltd., Shanghai, China

Ekta Mahajan, Program Director, Pharma Technical Regulatory, Genentech, a Member of the Roche Group, South San Francisco, USA


Session 4: Regulatory development in Asia
Session chairs:

Dorothee Ambrosius, Former Head of CMC Strategy Biologicals, Boehringer Ingelheim, Biberach, Germany

Scott Wheelwright, Co-founder and Principal Consultant, Complya Asia, Co. Ltd., Suzhou, China

Thursday 29 October 2020


Session 5: Cell and gene therapy: mapping innovation required for manufacturing
Session chairs:

Hari Pujar, Chief Technology Officer, Spark Therapeutics, Inc., Philadelphia, USA

Mats Lundgren, Customer Applications Director, GE Healthcare Life Sciences, Uppsala, Sweden


Session 6: Demystifying Biopharma 4.0
Session chairs:

Anurag Rathore, Professor, Department of Chemical Engineering, Indian Institute of Technology, New Delhi, India


Uwe Gottschalk, Chief Scientific Officer, Lonza, Switzerland


Session 7: Poster Session
Session chairs:

Linda Hwee-Lin Lua, Professor & Protein Expression Facility Director, University of Queensland, Brisbane, Australia

Balaji Somasundaram, Strategy and Operations Manager, Protein Expression Facility, University of Queensland, Brisbane, Australia

BPA 2020 Call for abstracts image

Download the Call for Abstracts here: BPA 2020 Call for abstracts


Full Text Call for Abstracts

Download the full Session texts here: BPA 2020 Full text Call for Abstracts


BPA in Review Small

Read the BioProcessing Asia Conference In Review at BIOPROCESSONLINE or download the eBook here: BioProcessing Asia Conference In Review.pdf